genprowebdirectory
Facebook Linkedin RSS Twitter Youtube
  • GEN Edge
    • Featured News
    • Multimedia
  • News
    • Insights
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • Magazine
    • Browse Issues
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • GEN Live
    • Learning Labs
    • Podcasts
  • Resources
    • eBooks/Perspectives
    • Tutorials
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
Search
Facebook Linkedin RSS Twitter Youtube
Sign in
Welcome! Log into your account
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
A password will be e-mailed to you.
Genetic Engineering & Biotechnology News GEN – Genetic Engineering and Biotechnology News
Genetic Engineering & Biotechnology News Genetic Engineering & Biotechnology News
  • GEN Edge
    • Featured News
    • Multimedia
  • News
    • Insights
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • Magazine
    • Browse Issues
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • GEN Live
    • Learning Labs
    • Podcasts
  • Resources
    • eBooks/Perspectives
    • Tutorials
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
Home 2022

Oncolytic virotherapy

Oncolytic Virotherapy Combined with Immunotherapy Tackles Resistant Cancer
Cancer

Oncolytic Virotherapy Combined with Immunotherapy Tackles Resistant Cancer

Sophia Ktori -
August 29, 2022
0
The Life Oncolytic, with Stephen Russell
Cancer

The Life Oncolytic, with Stephen Russell

Kevin Davies -
February 26, 2021
18
Novel Oncolytic Virus-Based Treatment Extends Survival in Pancreatic Cancer Models
Cancer

Novel Oncolytic Virus-Based Treatment Extends Survival in Pancreatic Cancer Models

Sophia Ktori -
January 27, 2021
0
Max Planck Partners with Themis Bioscience to Develop Oncolytic Virotherapies
News

Max Planck Partners with Themis Bioscience to Develop Oncolytic Virotherapies

GEN Staff Writer -
October 11, 2018
0
Interaction of Oncolytic Viruses Observed with Both Tumor and Healthy Cells
News

Interaction of Oncolytic Viruses Observed with Both Tumor and Healthy Cells

GEN Staff Writer -
September 10, 2018
0
Boehringer Ingelheim to Co-Develop ViraTherapeutics’ Oncolytic Virus Platform, Candidate
Drug Discovery

Boehringer Ingelheim to Co-Develop ViraTherapeutics’ Oncolytic Virus Platform, Candidate

GEN Staff Writer -
September 28, 2016
0
Enlisting Viruses in the Fight against Cancer
Cancer

Enlisting Viruses in the Fight against Cancer

GEN Staff Writer -
March 6, 2014
0
Virotherapy as a Key to Cancer Treatment
News

Virotherapy as a Key to Cancer Treatment

Brad Thompson, Ph.D. -
January 4, 2013
0
Oncolytic Virus Therapy Firms Merge
Cancer

Oncolytic Virus Therapy Firms Merge

GEN Staff Writer -
October 23, 2012
0
Cold Genesys Buys BioSante’s Oncolytic Virus Technology
Cancer

Cold Genesys Buys BioSante’s Oncolytic Virus Technology

GEN Staff Writer -
November 17, 2010
0

Read the Digital Edition

August 2023 cover

Explore

  • About GEN
  • Contact GEN
  • GEN Staff
  • Editorial Guidelines
  • Reprints and Permissions
  • Scientific Advisory Board

Advertise

  • Media Kit and Planning Calendar
  • Advertising Terms and Conditions

Resources

  • Get the GEN Magazine
  • Get the GEN Email Newsletter
  • Inside Precision Medicine
  • Privacy Policy
Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.
Scroll Up